Herb Estrogen F6: Menopause with high LDL or TC, hypertension, migraine or vascular headache, insomnia, dizziness and stroke.
1. Menopause: 176 menopause patients were treated with F6 and acupuncture for a month. Of them, 137 were cured (77.84 percent), 33 improved (18.75 percent) and only 6 (3.41 percent) did not improve.
2. High Cholesterol or Hyperlipidemic: Fourteen patients were treated with F6, and there are significant differences before and after treatment, P<0.05 or P<0.01.
3. Hypertension: Two reports on148 patients indicate the F6 formula is very effective in treating hypertension. Total effective rate is more than 96 percent.
4. Dizziness: Three reports on 175 patients using the F6 formula from one to four weeks showed the following results: 135 patients were cured (77.14 percent), 38 significantly improved (21.71 percent) and only 2 patients did not respond to the treatment.
5. Belly's Palsy syndrome: 46 patients showed great results with the F6 formula. 32 were cured (69.56 percent) with no remission in six months; 8 cases (17.39 percent) significantly improved with few muscle spasms and 6 are improved (13.04 percent). Another 30 patients taking F6 reported similar effects.
6. Headache: 300 headache patients were divided into two groups. The treatment group had a cure rate (no headache, no remission in six months and improved memory) of 90 percent, while the comparison group using analgesics, antidepressants and antiacids reached a cure rate of only 23.33 percent, p<0.01.
7. Stroke: Five reports on 1074 stroke patients including ischemic (n=721) and hemorrhagic (n=353) stroke patients, took the F6 formula from one month to six months and results are: 387 clinically cured (36.03%), 275 significantly improved (25.61%), 281 improved (26.16%), 51 no improvement (4.75%) and 80 deaths (7.45%). The average treatment period is around 45 days. More than 10 other reports on 400+ stroke patients also showed similar results. Here is the latest news from the American Stroke Association regarding using herbs to treat stroke patients.
8. Pediatric seizure: 15 patients taking F6 from one to six months showed the following results are: 8 significantly improved (75% fewer seizures), 8 improved (50% to 70 % fewer seizures) and 3 slightly improved (25 to 50% fewer attacks).
Toxicity and side effect: Five out of 168 patients taking the F6 formula experienced slight thirst. Otherwise, 56 liver tests, 57 urine tests and 77 blood tests from patients taking F6 were all normal. No toxicity has been reported.
